ILMN:NASDAQ
Illumina Inc
$270.00
arrow_downward
-1.42%(-3.90) 1D
$267.77
arrow_downward
-0.83% (-2.23)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$272.16
High
$276.97
Low
$267.66
Mkt. cap
40.77B
Avg. vol.
3.12M
Volume
5.03M
P/E ratio
50.18
52-wk high
$277.95
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$272.16
High
$276.97
Low
$267.66
Mkt. cap
40.77B
Avg. vol.
3.12M
Volume
5.03M
P/E ratio
50.18
52-wk high
$277.95
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
News Corp
·
2 days ago
Illumina Inc. stock underperforms Friday when compared to competitors
Yahoo Finance
·
2 days ago
Illumina Stock Popped 7% to a 52-Week High. Here’s Where the Stock Goes From Here
Yahoo Finance
·
3 days ago
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com